Hospice Quality Score Assessment Post Pharmacist Intervention

NCT04361669 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-09-07

No results posted yet for this study

Summary

The study aims to investigate the impact of pharmacist delivered interventions on hospice patients quality metric scores.

Conditions

Interventions

OTHER

Medication safety review

Implementation of a medication safety review using a clinical decision support system

Sponsors & Collaborators

  • Tabula Rasa HealthCare

    lead INDUSTRY

Principal Investigators

  • Jennifer Bingham, PharmD · Tabula Rasa HealthCare

Eligibility

Min Age
18 Years
Max Age
88 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-22
Primary Completion
2022-09-01
Completion
2022-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04361669 on ClinicalTrials.gov